Ziwei Tu

605 total citations
31 papers, 415 citations indexed

About

Ziwei Tu is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Ziwei Tu has authored 31 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Otorhinolaryngology. Recurrent topics in Ziwei Tu's work include Head and Neck Cancer Studies (9 papers), RNA modifications and cancer (4 papers) and Brain Metastases and Treatment (3 papers). Ziwei Tu is often cited by papers focused on Head and Neck Cancer Studies (9 papers), RNA modifications and cancer (4 papers) and Brain Metastases and Treatment (3 papers). Ziwei Tu collaborates with scholars based in China, United States and Hong Kong. Ziwei Tu's co-authors include Yunfei Xia, Yalan Tao, Chen Qu, Tianzhu Lu, Jin Gao, Hui Chang, Jingao Li, Xiaochang Gong, Yunfei Xia and Guo‐Kai Feng and has published in prestigious journals such as Journal of Applied Physics, Frontiers in Immunology and International Journal of Biological Macromolecules.

In The Last Decade

Ziwei Tu

31 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziwei Tu China 12 186 106 101 81 66 31 415
Juying Zhou China 11 115 0.6× 66 0.6× 63 0.6× 52 0.6× 15 0.2× 39 354
Blaž Grošelj Slovenia 12 296 1.6× 131 1.2× 56 0.6× 67 0.8× 18 0.3× 19 439
Lata Singh India 12 188 1.0× 122 1.2× 68 0.7× 39 0.5× 9 0.1× 63 455
Zhiying Shao China 12 174 0.9× 95 0.9× 69 0.7× 117 1.4× 19 0.3× 38 493
Yunwei Han China 13 293 1.6× 116 1.1× 166 1.6× 86 1.1× 11 0.2× 28 453
Dominique Coco United States 7 111 0.6× 186 1.8× 152 1.5× 105 1.3× 13 0.2× 9 503
Peter Szaniszlo United States 10 189 1.0× 54 0.5× 53 0.5× 19 0.2× 21 0.3× 19 349
Jonathan Zorea Israel 9 145 0.8× 113 1.1× 48 0.5× 42 0.5× 11 0.2× 12 269
Gayatri Gogoi India 9 99 0.5× 70 0.7× 51 0.5× 38 0.5× 8 0.1× 34 271
Jonah D. Klein United States 9 116 0.6× 144 1.4× 69 0.7× 37 0.5× 31 0.5× 14 307

Countries citing papers authored by Ziwei Tu

Since Specialization
Citations

This map shows the geographic impact of Ziwei Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwei Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwei Tu more than expected).

Fields of papers citing papers by Ziwei Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziwei Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwei Tu. The network helps show where Ziwei Tu may publish in the future.

Co-authorship network of co-authors of Ziwei Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Ziwei Tu. A scholar is included among the top collaborators of Ziwei Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziwei Tu. Ziwei Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xiong, Shuping, et al.. (2024). Which is the safer option for adult patients between peripherally inserted central catheters and midline catheters: a meta-analysis. Infection Control and Hospital Epidemiology. 46(1). 27–34. 1 indexed citations
3.
Ding, Xi, Yi‐Jun Hua, Xiong Zou, et al.. (2023). Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study. EClinicalMedicine. 61. 102043–102043. 8 indexed citations
4.
Zong, Lanlan, Yanling Wang, Shiyu Song, et al.. (2023). Formulation and Evaluation on Synergetic Anti-Hepatoma Effect of a Chemically Stable and Release-Controlled Nanoself-Assembly with Natural Monomers. International Journal of Nanomedicine. Volume 18. 3407–3428. 7 indexed citations
5.
Yuan, Jingjing, Shouhua Zhang, Dan Gong, et al.. (2022). A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model. Oncology Research and Treatment. 45(9). 471–479. 1 indexed citations
6.
Lu, Tianzhu, Qiao‐Li Lv, Min Fang, et al.. (2022). A Signature of N6-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 13. 809872–809872. 13 indexed citations
7.
Lu, Tianzhu, Xiaochang Gong, Qiao‐Li Lv, et al.. (2021). High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 11. 608842–608842. 23 indexed citations
9.
Tu, Ziwei, et al.. (2021). Limited recurrence distance of glioblastoma under modern radiotherapy era. BMC Cancer. 21(1). 720–720. 21 indexed citations
10.
Zhang, Mengxia, Li Wang, Lei Zeng, & Ziwei Tu. (2021). LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma. Frontiers in Oncology. 10. 605777–605777. 13 indexed citations
11.
Wang, Li, Mengxia Zhang, Meifang Zhang, & Ziwei Tu. (2020). ZBTB7A functioned as an oncogene in colorectal cancer. BMC Gastroenterology. 20(1). 8 indexed citations
12.
Wang, Li, et al.. (2020). Microbial etiology, susceptibility profile of postradiation nasopharyngeal necrosis patients with nasopharyngeal carcinoma. Cancer/Radiothérapie. 24(2). 93–98. 2 indexed citations
13.
Xie, Chen, et al.. (2019). Origin recognition complex subunit 1 regulates cell growth and metastasis in glioma by altering activation of ERK and JNK signaling pathway. Molecular and Cellular Probes. 49. 101496–101496. 11 indexed citations
14.
Zhou, Ciming, Li Qian, Xi Chen, et al.. (2018). Demodulation of a Hydroacoustic Sensor Array of Fiber Interferometers Based on Ultra-Weak Fiber Bragg Grating Reflectors Using a Self-Referencing Signal. Journal of Lightwave Technology. 37(11). 2568–2576. 35 indexed citations
16.
Chen, Chen, Yi Wei, Jin Gao, et al.. (2014). Alternative endpoints to the 5-year overall survival and locoregional control for nasopharyngeal carcinoma: A retrospective analysis of 2,450 patients. Molecular and Clinical Oncology. 2(3). 385–392. 13 indexed citations
18.
Tao, Yalan, Yan Li, Jin Gao, et al.. (2012). Identifying FGA peptides as nasopharyngeal carcinoma‐associated biomarkers by magnetic beads. Journal of Cellular Biochemistry. 113(7). 2268–2278. 23 indexed citations
19.
Li, Jianghua, Ziwei Tu, Zhiyuan Shen, et al.. (2012). Quantitative measurement of optical attenuation coefficients of cell lines CNE1, CNE2, and NP69 using optical coherence tomography. Lasers in Medical Science. 28(2). 621–625. 10 indexed citations
20.
Li, Jianghua, Zhiyuan Shen, Yonghong He, et al.. (2012). Quantitative measurement on optical attenuation coefficient of cell lines 5-8F and 6-10B using optical coherence tomography. Journal of Applied Physics. 112(8). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026